| $255M | ||
| $48M | ||
| $38M | ||
| $37M | ||
| $34M | ||
| $34M |
Buys | $98,325 | 1 | 100 |
Sells | $0 | 0 | 0 |
| Zhu Theodore | director | 1 | $98,325 | 0 | $0 | $98,325 |
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture …
Over the last 12 months, insiders at Axe Compute Inc. have bought $98,325 and sold $0 worth of Axe Compute Inc. stock.
On average, over the past 5 years, insiders at Axe Compute Inc. have bought $98,325 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Zhu Theodore (director) — $98,325.
The last purchase of 8,750 shares for transaction amount of $98,325 was made by Zhu Theodore (director) on 2026‑09‑08.
| 2026-09-08 | Zhu Theodore | director | 8,750 0.0444% | $11.24 | $98,325 | -2.71% |
| Increased Positions | 14 | +155.56% | 150,244 | +657.93% |
| Decreased Positions | 4 | -44.44% | 21,919 | -95.98% |
| New Positions | 9 | New | 147,741 | New |
| Sold Out Positions | 2 | Sold Out | 21,827 | Sold Out |
| Total Postitions | 19 | +111.11% | 151,161 | +561.94% |